21st Century Cures Act
Research!America president and CEO Mary Woolley was quoted in STAT News in support of the 21st Century Cures Act but expressed disappointment that the Prevention and Public Health Fund was used to offset the cost of the legislation. Woolley was also quoted about the Cures bill in FDA Week, Medpage Today, and The Cancer Letter.
Ellie Dehoney, Research!America's VP of policy and advocacy, was quoted on NPR News – All Things Considered praising the Cures legislation inclusion of the cancer moonshot initiative. Dehoney was also quoted in S&P Global, Modern Healthcare, and POLITICO Pro about the bill.
Research!America Post-Election Briefing
The Hon. John E. Porter Research!America Chair; the Hon. Michael N. Castle, Research!America vice chair; the Hon. Louis Sullivan M.D.; and Research!America board member and AAAS CEO Rush Holt, Ph.D. were among the panelists at Research!America’s post-election briefing on Nov. 15. They were quoted in STAT News, AAAS News, and BloombergBNA about the prospects for medical research in the new Congress along with other issues.
In a Nature article about president-elect Donald Trump’s selection of Rep. Tom Price, Research!America board member Georges Benjamin, M.D., director of the American Public Health Association, commented that the public health community will work with him, if confirmed, and emphasize prevention as an important health issue.
Trump Administration’s Scientific Priorities
In a Nature article about the incoming U.S. President’s scientific priorities, Mary Woolley said that his silence on biomedical science suggest that it may not a priority for the next Administration. “A lot of it is not really controversial. We tend in this country to take progress for granted,” said Woolley.
Keith R. Yamamoto, Ph.D., Research!America board member and executive vice dean of the school of medicine at University of California, San Francisco, was quoted in an NPR news article about the outlook for the NIH in a Trump Administration.
Campaign for Cures
A podcast from Genetic Engineering & Biotechnology News featured comments from Mary Woolley about key research related issues the next president will likely confront.
Woolley also penned an op-ed on Damon Runyon Cancer Research Foundation blog about the research priorities for the administration. “The next President's first budget for science and health agencies should be bold, so as to further embolden the next Congress,” she wrote.
A video from Medscape featured Research!America board member and National Academy of Medicine president, Victor Dzau, M.D., discussing a framework for countering emerging infectious disease outbreaks and pandemics.